MasTec (MTZ US)
MTZ US$181.00
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Advanced charting functionality with the ability to amend timeframes, chart type & indicator selection, powered by TradingView.
Share price activity
Displays share price activity. Volume = number of shares traded, Turnover = value of shares traded, VWAP = volume-weighted average price for the day, sourced from Morningstar.
- Last (Price)
- 181.00
- Change
- ▲ 4.50 (2.55)
- Bid / Ask
- 180.83 - 180.97
- Volume
- 420,318
- Turnover
- 69,789,709
- Open
- 181.87
- Day Range
- 176.97 - 182.78
- VWAP
- 180.98
- Prev Close
- 176.50
- Last Trade
- 28/10 4:10pm
Key information
Displays key information on the security, sourced from Morningstar.
- Sector
- Industrials
- Shares Issued
- 80,304,948
- NTA/Share
- 5.44
- Last Dividend
- —
- Dividend Ex Date
- —
- Dividend Pay Date
- —
Current (USD) · FY2025
Displays key financial data for the most recent fiscal year, in millions. Note - Per share data is in local currency terms irrespective of reporting currency, and may be different to the stated currency, sourced from Morningstar.
- Revenue
- 14,299.17
- EBITDA
- 1,115.47
- Profit
- 399.04
- Earnings Per Share (EPS)
- 5.07
- Dividend Per Share (DPS)
- —
- Yield %
- 0.00
- Market Cap
- 14,535.20
- Price to Earnings Ratio (P/E)
- 28.82
Estimates (USD) · FY2027
Displays consensus analyst’s estimates for key measures for the next fiscal year, sourced from Morningstar.
- Revenue
- 21,695.66
- EBITDA
- 1,943.50
- Profit
- 967.09
- Earnings Per Share (EPS)
- 12.05
- Dividend Per Share (DPS)
- 0.00
Quantitative rating
Displays Morningstar’s Quantitative Equity Research Rating for the security: a star rating from 1 (overvalued) to 5 (undervalued) from the share price against a fair value estimated by a statistical model of Morningstar’s analyst ratings, with the model’s economic moat, financial health and fair value uncertainty, sourced from Morningstar.
Undervalued
- Economic Moat
- None
- Financial Health
- Moderate
- Uncertainty
- High
Morningstar Quantitative Rating as of 28 OCT 2026.
Quantitative Equity Rating Methodology – view here
Fair value estimate
Displays Morningstar’s quantitative fair value estimate for the security against the current share price, with the band around it: the five-star price below which the model would rate the stock five stars and the one-star price above which it would rate it one star, sourced from Morningstar.
Five-star price 179.27 Fair value 209.24 One-star price 244.22
Morningstar Quantitative Rating as of 28 OCT 2026.
Quantitative valuation
Displays where the share price sits in Morningstar’s quantitative fair value band, from the five-star price (undervalued) to the one-star price (overvalued), with the fair value estimate, the price to fair value ratio, the model’s valuation label and its uncertainty rating, sourced from Morningstar.
Buy
Sell
- Fair Value
- 209.24
- Price / Fair Value
- 0.87
- Valuation
- Undervalued
- Uncertainty
- High
Morningstar Quantitative Rating as of 28 OCT 2026. The slider runs from the five-star price (179.27) to the one-star price (244.22).
Displays useful ratios for the security, NB the pricing date used, sourced from Morningstar.
| Ratios |
|---|
| Currency (Price/reporting): USD/USD |
| Exchange Rate: 1.0000 |
Price, volume and trading statistics for the security, sourced from Morningstar.
| Price - closing or last bid | 181.00 |
| Price - 12 month high | 440.30 |
| Price - 12 month low | 164.33 |
| Pricing date | 27 OCT 2026 |
| Volume - avg. trading volume for the last ten days | 1.35 |
| Market capitalization | 14,535.20 |
| 12 Month High price date | 6 MAY 2026 |
| 12 Month Low price date | 23 OCT 2026 |
| Volume - avg. trading volume for the last 3 months | 1.53 |
| Price - 1 Day % Change | 2.55% |
| Price - 13 week price percent change | -42.07% |
| Price - 26 week price percent change | -51.74% |
| Price - 5 Day % Change | 0.02% |
| Price - 52 week price percent change | -14.64% |
| Price - YTD price percent change | -17.85% |
| Price % Change Month To Date | -11.31% |
Earnings, dividends, cash flow and book value per share, sourced from Morningstar.
| EPS excluding extraordinary items - most recent fiscal year | 5.070 |
| EPS excluding extraordinary items - trailing 12 month | 6.270 |
| EPS Normalized - most recent fiscal year | 6.550 |
| Revenue/share - most recent fiscal year | 181.706 |
| Revenue/share - trailing 12 month | 204.630 |
| Book value per share - most recent fiscal year | 41.311 |
| Book value per share - most recent quarter | 43.964 |
| Book value (tangible) per share - most recent fiscal year | 5.441 |
| Book value (tangible) per share - most recent quarter | 6.453 |
| Cash per share - most recent fiscal year | 5.020 |
| Cash per share - most recent quarter | 3.991 |
| Cash Flow per share - most recent fiscal year | 12.139 |
| Cash Flow per share - trailing 12 month | 14.331 |
| Dividend per share - most recent fiscal year | — |
| Dividends per share - trailing 12 month | 0.000 |
| EBITD per share - trailing 12 month | 16.675 |
| EPS Basic excluding extraordinary items - most recent fiscal year | 5.120 |
| EPS Basic excluding extraordinary items - trailing 12 month | 6.350 |
| EPS including extraordinary items - most recent fiscal year | 5.120 |
| EPS including extraordinary items - trailing 12 month | 6.350 |
| Free Cash Flow per share - trailing 12 month | 10.048 |
Valuation multiples such as P/E, price to sales, price to book and enterprise value ratios, sourced from Morningstar.
| P/E excluding extraordinary items, most recent fiscal year | 28.87 |
| P/E Normalized, most recent fiscal year | 22.18 |
| Price to sales - most recent fiscal year | 0.88 |
| Price to Tangible Book - most fiscal year | 36.95 |
| Price to Free Cash Flow per Share - most recent fiscal year | 18.01 |
| Price to Cash Flow per share - trailing 12 month | 12.63 |
| Price to Book - most recent fiscal year | 4.12 |
| P/E excluding extraordinary items high, trailing 12 months | 76.62 |
| P/E excluding extraordinary items low, trailing 12 months | 27.28 |
| Net Debt, LFI | 2,919.81 |
| Net Debt, LFY | 2,403.14 |
| Dividend Yield - 5 Year Average | — |
| Dividend Yield - indicated annual dividend divided by closing price | — |
| Current Dividend Yield - Common Stock Primary Issue, LTM | 0.00% |
Cash flow, liquidity and leverage measures, sourced from Morningstar.
| Free Cash Flow - most recent fiscal year | 695.28 |
| LT debt/equity - most recent fiscal year | 74.05% |
| Payout ratio - most recent fiscal year | — |
| Total debt/total equity - most recent fiscal year | 83.95% |
| LT debt/equity - most recent quarter | 80.22% |
| Total debt/total equity - most recent quarter | 89.87% |
| Free Cash Flow - trailing 12 month | 790.97 |
| Payout ratio - trailing 12 month | — |
Key income statement lines for the most recent fiscal year, in millions, sourced from Morningstar.
| Revenue - most recent fiscal year | 14,299.17 |
| Revenue - trailing 12 month | 16,109.10 |
| EBITD - most recent fiscal year | 1,115.47 |
| EBITD - trailing 12 month | 1,312.67 |
| Earnings before taxes - most recent fiscal year | 515.40 |
| Earnings before taxes - trailing 12 month | 670.85 |
| Net Income available to common - most recent fiscal year | 399.04 |
| Net Income available to common - trailing 12 months | 494.33 |
| Earnings before taxes Normalized - most recent fiscal year | 530.95 |
| Net Income Available to Common, Normalized - most recent fiscal year | 538.20 |
| Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM | 8.16 |
Profitability margins for the most recent fiscal year, sourced from Morningstar.
| Net Profit Margin % - 1st historical fiscal year | 2.95% |
| Net Profit Margin % - trailing 12 month | 3.32% |
| Operating margin - 1st historical fiscal year | 4.56% |
| Operating margin - trailing 12 month | 5.14% |
| Pretax margin - trailing 12 month | 4.16% |
| Pretax margin - 1st historical fiscal year | 3.60% |
| Operating Margin - 5 year average | 3.06% |
| Pretax Margin - 5 year average | 2.16% |
| Free Operating Cash Flow/Revenue, 5 Year Average | 4.06% |
| Free Operating Cash Flow/Revenue, TTM | 4.91% |
| Net Profit Margin - 5 year average | 1.74% |
Returns on average assets and equity for the fiscal year, the trailing 12 months and as 5 year averages, and net income and revenue per employee in whole currency, sourced from Morningstar.
| Return on average assets - most recent fiscal year | 4.53% |
| Return on average assets - trailing 12 month | 5.34% |
| Return on average equity - most recent fiscal year | 13.96% |
| Return on average equity - trailing 12 month | 16.61% |
| Return on average assets - 5 year average | 2.38% |
| Return on average equity - 5 year average | 7.03% |
| Net Income/employee - most recent fiscal year | 11,722.61 |
| Revenue/employee - most recent fiscal year | 397,199.19 |
Growth in revenue, earnings, dividends and book value over recent periods, sourced from Morningstar.
| Revenue growth rate, 5 year | 17.73% |
| EPS growth rate, 5 year | 2.97% |
| Growth rate% - dividend, 3 year | — |
| Revenue/share (5 yr growth) | 16.21% |
| Growth rate% - Revenue, 3 year | 13.51% |
| Growth rate% - EPS, 3 year | 129.40% |
| Book value per share growth rate, 5 year | 8.88% |
| Capital Spending growth rate, 5 year | 3.99% |
| Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR | 7.35% |
Displays analyst’s forecasts for key measures. The estimates can be expanded to see the spread of the calls. Full lines = reported, and dotted lines are forward estimates. Click a measure to add or remove it from the chart, sourced from Morningstar.
Financial forecast (USD, millions except per share)
| Actuals | Estimates | |||||||
| 2025 | 2026 | 2027 | 2028 | 2029 | ||||
| Estimate breakdown | ||||||||
Financial metrics can be plotted on the graph to see trends. Multiple metrics from multiple statements can be plotted against each other, sourced from Morningstar.
Financials (USD, millions)
| Period end: | DEC 21 | DEC 22 | DEC 23 | DEC 24 | DEC 25 |
| Fiscal year: | 2021 | 2022 | 2023 | 2024 | 2025 |
| Period length: | 12 months | 12 months | 12 months | 12 months | 12 months |
Displays all company announcements released by the company to the exchange, sourced from Morningstar.
Announcements
Announcements are available for ASX-listed companies only.
Opinion
No opinions for this company yet.
Action
No actions for this company yet.
Business Summary
MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. Its primary activities include engineering, building, installing, maintaining, and upgrading communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five segments: communications; clean energy and infrastructure; pipeline infrastructure; power delivery; and other.
Relevant suggested news and content from the site
Video
WATCH
Webinar Recording: Are commodities entering a Supercycle?
Recorded Wednesday 24th June @ 12.30pm
Podcast
LISTEN
Thursday 11th September – Dow off -220pts, SPI off -20pts
Daily Podcast Direct from the Desk
Video
WATCH
Buy Hold Sell: The 6 income stocks readers love, plus 2 expert ideas
Recorded 10th June 2026
Podcast
LISTEN
Wednesday 10th September – Dow up +196pts, SPI down -4pts
Daily Podcast Direct from the Desk
